Posts

Asepsis Medical Technologies announces the Notice of Allowance of Australian Patent Application 2013222819 for its Safe-T-Dose® combinatorial drug injection kit. The Asepsis’ Calibrated Drug Delivery™

Asepsis Medical Technologies announces the USPTO grant of Patent Application 14/059,070 for its Safe-T-Fuse™ drug infusion system. The Safe-T-Fuse™ is an industry unique infusion container that allows

Asepsis announces the USPTO grant of U.S. Patent 9,302,050 for its combinatorial, Calibrated Drug Delivery™ (CDD) platform. The 050 patent continuation further enhances the reconstitution aspects of t

Independent formative usability studies were completed on the Asepsis pediatric Calibrated Drug Delivery™ Kits in Chicago, Illinois. The ANSI/AAMI HIE75:2009 and ANSI/AAMI/IEC 62366:2007 studies were

Asepsis Medical Technologies announces the issuance of U.S. Patent 9,192,723, for its combinatorial drug injection systems. The Asepsis’ Calibrated Drug Delivery™(CDD) platform is designed to eliminat

Asepsis announces the patent pending, Vi-Injection kit™. This combinatorial medicinal injection kit is designed for enhancing the safety and accuracy of a self-injection by a vision impaired (VI) pati

Asepsis announces the patent pending Vi-Syringe™. The Vi-Syringe™ is the world’s first ergonomically designed hypodermic syringe that allows a visually impaired user to independently prepare and admin

Asepsis announces the patent pending Momenta-Dose™, a parenteral injection device designed to administer an injection solely by a user’s applied force and subsequent momentum. This autogenic momentum

Asepsis announces the patented, industry unique Safe-T-Syringe®. The unique flat panel displays of the Safe-T-Syringe® comprises a multitude of correlating measurements of its contents without the nee

Asepsis announces the patent pending Safe-T-Fuse™. This industry unique infusion bag allows the contents of a standard vial to be quickly introduced to an integrated diluent reservoir without the use